185 related articles for article (PubMed ID: 22160140)
1. Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells.
Shin H; Lee YS; Lee YC
Oncol Rep; 2012 Apr; 27(4):1111-5. PubMed ID: 22160140
[TBL] [Abstract][Full Text] [Related]
2. Sodium butyrate-induced death-associated protein kinase expression promote Raji cell morphological change and apoptosis by reducing FAK protein levels.
Zhang HT; Feng ZL; Wu J; Wang YJ; Guo X; Liang NC; Zhu ZY; Ma JQ
Acta Pharmacol Sin; 2007 Nov; 28(11):1783-90. PubMed ID: 17959029
[TBL] [Abstract][Full Text] [Related]
3. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells.
Condorelli F; Gnemmi I; Vallario A; Genazzani AA; Canonico PL
Br J Pharmacol; 2008 Feb; 153(4):657-68. PubMed ID: 18059320
[TBL] [Abstract][Full Text] [Related]
5. DAPK plays an important role in panobinostat-induced autophagy and commits cells to apoptosis under autophagy deficient conditions.
Gandesiri M; Chakilam S; Ivanovska J; Benderska N; Ocker M; Di Fazio P; Feoktistova M; Gali-Muhtasib H; Rave-Fränk M; Prante O; Christiansen H; Leverkus M; Hartmann A; Schneider-Stock R
Apoptosis; 2012 Dec; 17(12):1300-15. PubMed ID: 23011180
[TBL] [Abstract][Full Text] [Related]
6. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors.
Terui T; Murakami K; Takimoto R; Takahashi M; Takada K; Murakami T; Minami S; Matsunaga T; Takayama T; Kato J; Niitsu Y
Cancer Res; 2003 Dec; 63(24):8948-54. PubMed ID: 14695212
[TBL] [Abstract][Full Text] [Related]
7. Gene expression associated with the decrease in malignant phenotype of human liver cancer cells following stimulation with a histone deacetylase inhibitor.
Wakabayashi K; Saito H; Kaneko F; Nakamoto N; Tada S; Hibi T
Int J Oncol; 2005 Jan; 26(1):233-9. PubMed ID: 15586245
[TBL] [Abstract][Full Text] [Related]
8. Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression.
Saito H; Ebinuma H; Takahashi M; Kaneko F; Wakabayashi K; Nakamura M; Ishii H
Hepatology; 1998 May; 27(5):1233-40. PubMed ID: 9581676
[TBL] [Abstract][Full Text] [Related]
9. The G1 phase arrest and apoptosis by intrinsic pathway induced by valproic acid inhibit proliferation of BGC-823 gastric carcinoma cells.
Zhao X; Yang W; Shi C; Ma W; Liu J; Wang Y; Jiang G
Tumour Biol; 2011 Apr; 32(2):335-46. PubMed ID: 21113745
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis in human gastric cancer by sodium butyrate.
Litvak DA; Hwang KO; Evers BM; Townsend CM
Anticancer Res; 2000; 20(2A):779-84. PubMed ID: 10810354
[TBL] [Abstract][Full Text] [Related]
11. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
Pei XY; Dai Y; Grant S
Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis of U937 human leukemic cells by sodium butyrate is associated with inhibition of telomerase activity.
Choi YH
Int J Oncol; 2006 Nov; 29(5):1207-13. PubMed ID: 17016653
[TBL] [Abstract][Full Text] [Related]
13. Modulation of butyrate anticancer activity by solid lipid nanoparticle delivery: an in vitro investigation on human breast cancer and leukemia cell lines.
Foglietta F; Serpe L; Canaparo R; Vivenza N; Riccio G; Imbalzano E; Gasco P; Zara GP
J Pharm Pharm Sci; 2014; 17(2):231-47. PubMed ID: 24934552
[TBL] [Abstract][Full Text] [Related]
14. Effects of tachyplesin and n-sodium butyrate on proliferation and gene expression of human gastric adenocarcinoma cell line BGC-823.
Shi SL; Wang YY; Liang Y; Li QF
World J Gastroenterol; 2006 Mar; 12(11):1694-8. PubMed ID: 16586536
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts.
Bernhard D; Ausserlechner MJ; Tonko M; Löffler M; Hartmann BL; Csordas A; Kofler R
FASEB J; 1999 Nov; 13(14):1991-2001. PubMed ID: 10544182
[TBL] [Abstract][Full Text] [Related]
16. Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cells.
Luo XJ; Li LL; Deng QP; Yu XF; Yang LF; Luo FJ; Xiao LB; Chen XY; Ye M; Liu JK; Cao Y
Eur J Cancer; 2011 Jan; 47(2):316-25. PubMed ID: 20943371
[TBL] [Abstract][Full Text] [Related]
17. Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells.
Kim J; Park H; Im JY; Choi WS; Kim HS
Anticancer Res; 2007; 27(5A):3285-92. PubMed ID: 17970072
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis induced by the sodium butyrate in human gastric cancer TMK-1 cells.
Tsai LC; Hung MW; Chang GG; Chang TC
Anticancer Res; 2000; 20(4):2441-8. PubMed ID: 10953308
[TBL] [Abstract][Full Text] [Related]
19. Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1).
Chopin V; Slomianny C; Hondermarck H; Le Bourhis X
Exp Cell Res; 2004 Aug; 298(2):560-73. PubMed ID: 15265702
[TBL] [Abstract][Full Text] [Related]
20. Interaction between ZBP-89 and p53 mutants and its contribution to effects of HDACi on hepatocellular carcinoma.
Zhang CZ; Chen GG; Merchant JL; Lai PB
Cell Cycle; 2012 Jan; 11(2):322-34. PubMed ID: 22214764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
